Ignite Creation Date:
2024-05-06 @ 7:51 AM
Last Modification Date:
2024-10-26 @ 11:53 AM
Study NCT ID:
NCT02617589
Status:
COMPLETED
Last Update Posted:
2023-03-28
First Post:
2015-11-26
Brief Title:
An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide Each Given With Radiation Therapy for Newly-diagnosed Patients With Glioblastoma GBM a Malignant Brain Cancer
Sponsor:
Organization:
Bristol-Myers Squibb